Effectiveness of Ramucirumab Plus Docetaxel for Advanced Non-Small Cell Lung Cancer Patients: a Cohort of 93 Patients

被引：0
|
作者：
Barcelos, Isabella Favato [1 ]
De Marchi, Pedro [1 ]
Aguiar Junior, Pedro Nazareth [1 ]
Montella, Tatiane Caldas [1 ]
Afonso, Nathalia Gimenes [1 ]
Visani, Filipe [1 ]
Negreiros, Izabella Santos [1 ]
De Cerqueira Mathias, Clarissa Maria [1 ]
Paes, Rafael Duarte [1 ]
Dienstmann, Rodrigo [1 ]
Ferreira, Carlos Gil [1 ]
机构：
[1] Oncoclin, Rio De Janeiro, Brazil
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP.11
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [41] Cobolimab With Dostarlimab and Docetaxel in Patients (pts) With Advanced Non-small Cell Lung Cancer (NSCLC): COSTAR Lung
    Kim, Hye Ryun
    Gridelli, Cesare
    Kapur, Dinesh
    Tufman, Amanda
    Felip, Enriqueta
    Velcheti, Vamsidhar
    Kim, Yu Jung
    Goetze, Thorsten
    Lopez, Pilar Garrido
    Corre, Romain
    Penkov, Konstantin
    Anjum, Rana
    Di Pace, Brian
    Liu, Wenlei
    Borgovan, Theo
    Ledger, Danielle
    Carver, Jennifer
    Waszak, Angela
    Dhar, Arindam
    Novello, Silvia
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 163 - 163
  • [42] COST EFFECTIVENESS ANALYSIS OF NIVOLUMAB PLUS IPILIMUMAB THERAPY IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER IN JAPAN
    Mo, X.
    Moriwaki, K.
    Morimoto, K.
    Shimozuma, K.
    VALUE IN HEALTH, 2022, 25 (01) : S118 - S119
  • [43] Chemotherapy in patients with advanced non-small cell lung cancer
    Price, A
    CLINICAL ONCOLOGY, 2001, 13 (06) : 480 - 482
  • [44] Advanced non-small cell lung cancer in elderly patients
    Quoix, Elisabeth
    BREATHE, 2012, 9 (01) : 27 - 34
  • [45] Comparative Effectiveness of Atezolizumab, Nivolumab, and Docetaxel in Patients With Previously Treated Non-Small Cell Lung Cancer
    Ramagopalan, Sreeram
    Gupta, Alind
    Arora, Paul
    Thorlund, Kristian
    Ray, Joshua
    Subbiah, Vivek
    JAMA NETWORK OPEN, 2021, 4 (11)
  • [46] Pemetrexed Plus Platinum for Patients With Advanced Non-small Cell Lung Cancer and Interstitial Lung Disease
    Fujita, Tetsuo
    Kuroki, Tsuguko
    Hayama, Nami
    Shiraishi, Yuka
    Amano, Hiroyuki
    Nakamura, Makoto
    Hirano, Satoshi
    Tabeta, Hiroshi
    Nakamura, Sukeyuki
    IN VIVO, 2019, 33 (06): : 2059 - 2064
  • [47] Phase I Expansion Cohort of Ramucirumab Plus Pembrolizumab in Advanced Treatment-Naive Non-Small Cell Lung Cancer (JVDF)
    Herbst, R.
    Arkenau, H.
    Bendell, J.
    Arrowsmith, E.
    Wermke, M.
    Soriano, A.
    Penel, N.
    Santana-Davila, R.
    Bischoff, H.
    Chau, I.
    Chao, B.
    Ferry, D.
    Mi, G.
    Paz-Ares, L.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S307 - S307
  • [48] Feasibility Study of Nivolumab and Docetaxel in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
    Shimokawa, T.
    Nakamura, Y.
    Iwasawa, S.
    Miyazaki, K.
    Yamanaka, T.
    Takiguchi, Y.
    Okamoto, H.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2431 - S2431
  • [49] Phase II Study of Docetaxel and Carboplatin in Elderly Patients with Advanced Non-small Cell Lung Cancer
    Yoshimura, Naruo
    Kudoh, Shinzoh
    Kimura, Tatsuo
    Mitsuoka, Shigeki
    Kyoh, Shigenoir
    Tochino, Yoshihiro
    Asai, Kazuhisa
    Kodama, Toyoki
    Ichimaru, Yukikazu
    Yana, Takashi
    Hirata, Kazuto
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (03) : 371 - 375
  • [50] Cisplatin with attenuated dose of docetaxel in Thai patients with advanced or recurrent non-small cell lung cancer
    Charoentum, Chaiyut
    Tharavijitkul, Ekapong
    Buranochokepaisarn, Manote
    Chewasakulyong, Busayamas
    Thongprasert, Sumitra
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S671 - S671
12345